Osteoclasts constitutively express regulators of bone resorption: An Immunohistochemical and in situ hybridization study

Laboratory Investigation

Volumn 76, Issue 4, 1997, Pages 457-465

  O'Keefe, Regis J ^a   Teot, Lisa A ^a   Singh, Divya ^a   Puzas, J Edward ^a   Rosier, Randy N ^a   Hicks, David G ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPERPARATHYROIDISM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; OSTEOCLAST; OSTEOLYSIS; OSTEOMYELITIS; PAGET BONE DISEASE; PRIORITY JOURNAL; REGULATOR GENE;

BONE AND BONES; BONE DISEASES; BONE RESORPTION; GIANT CELL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERLEUKIN-1; INTERLEUKIN-6; OSTEOCLASTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031004289     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Bataille R, Chappard D, and Klein B (1992). The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma, Int J Clin Lab Res 21:283-287.
2. Bellido T, Girasole G, Passeri G, Yu XP, Mocharla H, Jilka RL, Notides A, and Manolagas SC (1993). Demonstration of estrogen and vitamin D receptors in bone marrow-derived stromal cells: Up-regulation of the estrogen receptor by 1:25-dihydroxyvitamin-D3. Endocrinology 133:553-562.
3. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJ, and Mundy GR (1989). Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 125:1142-1150.
4. Chaudhary LR, Spelsberg TC, and Riggs BL (1992). Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: Lack of regulation by 17 beta-estradiol. Endocrinology 130:2528-2534.
5. Crabb ID, Hughes SS, Hicks DG, Puzas JE, Tsaw GI, and Rosier RN (1992). Non-radioactive in situ hybridization using digoxigenin labeled oligonucleotides: Applications to musculoskeletal tissues. Am J Pathol 141:579-589.
6. de la Mata J, Uy HL, Guise TA, Story B, Boyce BF, Mundy GR, and Roodman GD (1995). Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J Clin Invest 95:2846-2852.
7. Dodds RA, Merry K, Littlewood A, and Gowan M (1994). Expression of mRNA for IL1 beta, IL6 and TGF beta 1 in developing human bone and cartilage. J Histochem Cytochem 42:733-744.
8. Fang MA and Hahn TJ (1991). Effects of interleukin-6 on cellular function in UMR-106-01 osteoblast-like cells. J Bone Miner Res 6:133-139.
9. Flanagan AM, Stow MD, Kendall N, and Brace W (1995). The role of 1:25-dihydroxycholecalciferol and prostaglandin E2 in the regulation of human osteoclastic bone resorption in vitro. Int J Exp Pathol 76:37-42.
10. Fuller K and Chambers TJ (1989). Effects of arachidonic acid metabolites on bone resorption by isolated rat osteoclasts. J Bone Miner Res 4:209-215.
11. Greenfield EM, Gornik SA, Horowitz MC, Donahue HJ, and Shaw SM (1993). Regulation of cytokine expression in osteoblasts by parathyroid hormone: Rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA. J Bone Miner Res 8:1163-1171.
12. Hicks DG, Gokan T, O'Keefe RJ, Totterman SM, Fultz PJ, Judkins AR, Meyers SP, Rubens DJ, Sickel JZ, and Rosier RN (1995). Primary lymphoma of bone: Correlation of magnetic resonance imaging features with cytokine production by tumor cells. Cancer 75:973-980.
13. Horowitz SM, Doty SB, Lane JM, and Burnstein AH (1993). Studies of the mechanism by which the mechanical failure of polymethyl-methacrylate leads to bone resorption. J Bone Joint Surg (Am) 75:802-813.
14. Hoyland JA, Freemont AJ, and Sharpe PT (1994). Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease. J Bone Miner Res 9:75-80.
15. Ikegame M, Rakopoulos M, Zhou H, Houssami S, Martin TJ, Moseley JM, and Findlay DM (1995). Calcitonin receptor isoforms in mouse and rat osteoclasts. J Bone Miner Res 10:59-65.
16. Ishibe M, Rosier RN, and Puzas JE (1991a). Activation of osteoblast insulin-like growth factor-II/cation-independent mannose-6-phosphate receptors by specific phosphorylated sugars and antibodies induce insulin-like growth factor-II effects. Endocr Res 17:357-366.
17. Ishibe M, Rosier RN, and Puzas JE (1991b). Human prostatic acid phosphatase directly stimulates isolated bone cells. Endocrinol Metab 73:785-782.
18. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, and Hirano T (1990). IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297-3303. and Harris WH (1993). Production of cytokines around loosened cemented acetabular components. J Bone Joint Surg 75A:863-879.
19. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, Yamaguchi A, Yoshiki S, Matsuda T, and Hirano T (1990). IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297-3303. and Harris WH (1993). Production of cytokines around loosened cemented acetabular components. J Bone Joint Surg 75A:863-879.
20. Jiranek WA, Machado M, Murali J, Jevsevar D, Wolfe HJ, Goldring SR, Goldberg MJ, and Harris WH (1993). Production of cytokines around loosened cemented acetabular components. J Bone Joint Surg 75A:863-879.
21. Johnson RA, Boyce BF, Mundy GR, and Roodman GD (1989). Tumors producing human tumor necrosis factor induce hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology 124:1424-1427.
22. Kurihara N, Bertolini D, Suda T, Akiyama Y, and Roodman GD (1990). IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol 144:4226-4230.
23. Kurihara N, Civin C, and Roodman GD (1991). Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype. J Bone Miner Res 6:257-261.
24. Lacey DL, Grosso LE, Moser SA, Erdmann J, Tan HL, Pacifici R, and Villareal DT (1993). IL-1-induced murine osteoblast IL-6 production is mediated by the type 1 IL-1 receptor and is increased by 1:25 dihydroxyvitamin D3. J Clin Invest 91:1731-1742.
25. Lowik CW, van der Pluijm G, Bloys H, Hoekman K, Bijvoet OL, Aarden LA, and Papapoulos SE (1989). Parathyroid hormone and PTH-like protein stimulated interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun 162: 546-552.
26. Manolagas SC and Jilka RL (1995). Bone marrow, cytokines, and bone remodeling: Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305-311.
27. Manolagas SC and Jilka RL (1992). Cytokines, hematopoiesis, osteoclastogenesis, and estrogens. Calcif Tissue Int 50:199-202.
28. Marshall MJ, Holt I, and Davie MW (1995). The number of tartrate-resistant acid phosphatase-positive osteoclasts on neonatal mouse parietal bones is decreased when prostaglandin synthesis is inhibited and increased in response to prostaglandin E2, parathyroid hormone, and 1:25 dihydroxyvitamin D3. Calcif Tissue Int 56:240-245.
29. McSheehy PM and Chambers TJ (1986). Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 118:824-828.
30. Middleton J, Arnott N, Walsh S, and Beresford J (1995). Osteoblasts and osteoclasts in adult human osteophyte tissue express the mRNAs for insulin-like growth factors I and II and the type 1 IGF receptor. Bone 16:287-293.
31. Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez-Valdez H, and Banchereau J (1992). Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. Arthritis Rheum 35:874-883.
32. Ohsaki Y, Takahashi S, Scarcez T, Demulder A, Nishihara T, Williams R, and Roodman GD (1992). Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumor of bone. Endocrinology 131:2229-2234.
33. Pacifici R, Carano A, Santoro SA, Rifas L, Jeffrey JJ, Malone JD, McCracken R, and Avioli LV (1991). Bone matrix constituents stimulate interleukin-1 release from human blood mononuclear cells. J Clin Invest 87:221-228.
34. Passeri G, Girasole G, Jilka RL, and Manolagas SC (1993). Increased interleukin-6 production by murine bone marrow. Endocrinology 133:822-828.
35. Pfeilschifter J, Chenu C, Bird A, Mundy GR, and Roodman GD (1989). Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclast-like cells in vitro. J Bone Miner Res 4:113-118.
36. Reddy SV, Takahashi S, Dallas M, Willeams RE, Nekers L, and Roodman GD (1994). Interleukin-6 antisense deoxyoligonucleotides inhibit bone resorption by giant cells from human giant cell tumors of bone. J Bone Miner Res 9:753-757.
37. Roodman GD (1992). Role of cytokines in the regulation of bone resorption. Calcif Tissue Int 53(Suppl 1):94-98.
38. Roodman GD, Kurihara N, Ohsaki Y, Kukita A, Hosking D, Demulder A, Smith JF, and Singer FR (1992). Interleukin 6: A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest 89:46-52.
39. Teot LA, O'Keefe RJ, Rosier RN, O'Connell JX, Fox EJ, and Hicks DG (1996). Extraosseous primary and recurrent giant cell tumors: Transforming growth factor-β1 and β-2 expression may explain metaplastic bone formation. Hum Pathol 27:625-632.
40. Thomson BM, Mundy GR, and Chambers TJ (1987). Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption. J Immunol 138:775-779.
41. Uy HL, Dallas M, Calland JW, Boyce BF, Mundy GR, and Roodman GD (1995). Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage. J Bone Miner Res 10:295-301.
42. Yoshimine Y, Tsukuba T, Isobe R, Sumi M, Akamine A, Maeda K, and Yamamoto K (1995). Specific immunocytochemical localization of cathepsin E at the ruffled border membrane of active osteoclasts. Cell Tissue Res 281:85-91.
43. Zheng MH, Wood DJ, Wysocki S, Papadimitriou JM, and Wang EA (1994). Recombinant human bone morphogenetic protein-2 enhances expression of interleukin-6 and transforming growth factor-beta 1 genes in normal human osteoblast-like cells. J Cell Physiol 159:76-82.
44. Zheng MH, Ying F, Wysocki SJ, Lau AT, Robertson T, Beilharz M, Wood DJ, and Papadimitriou JM (1994). Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone: Possible involvement in osteoclast-like cell migration. Am J Pathol 145:1095-1104.